High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Swaziland PCR Laboratory Technician Training Contract |
Michelle Hsiang, MD |
Malaria |
|
|
Swaziland Serology Technical Assistance |
Michelle Hsiang, MD |
Malaria, Drug and Diagnostics Development |
|
|
Evaluation of Falcipain as an Antimalarial Drug Target |
Philip J. Rosenthal, MD |
Malaria |
|
|
Training In Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building |
|
|
A Functional Genomics Approach to Identification of New Anti-Malarial Drug Targets |
Joseph Derisi, PhD |
Malaria |
|
|
A Genome Wide Characterization of the Erythrocytic Cell Cycle of the Human Parasite Plasmodium |
Joseph Derisi, PhD |
Malaria |
|
|
Drug Resistant Malaria Clinical and Laboratory Studies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Development of Falcipain Inhibitors as Antimalarial Drugs |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Global Malaria Prevention and Control |
Philip J. Rosenthal, MD |
Malaria |
|
|
Novel Anti-Malarials by Combinatorial Pharmacogenomics |
Joseph Derisi, PhD |
Infectious Disease, Malaria, Drug and Diagnostics Development |
|
|
Monitoring and Evaluation of a Malaria Control Program in Vanuatu |
|
Malaria, Epidemiology and Surveillance |
|
|
Global Health Initiatives |
|
Malaria, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening |
|
|
Examination of genome instability in Plasmodium Falciparum using functional genomics |
|
Malaria, Genetics |
|
|
Clinical and Molecular Studies of Drug Resistant Malaria [I] |
Philip J. Rosenthal, MD |
Malaria |
|
|
Clinical and Molecular Studies of Drug-Resistant Malaria [II] |
Grant Dorsey, MD |
Malaria |
|
|
Cultural and Behavioral Factors Related to Malaria Transmission and Control among Hmong and Other Minority Ethnic Groups in Mainland Southeast Asia |
|
Malaria |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Host Polymorphisms and Uncomplicated Malaria |
Sunil Parikh, MD, MPH |
Malaria |
|
|
Clinical Studies of Interactions Between HIV and Malaria |
Diane Havlir, MD |
HIV/AIDS, Malaria |
|
|
Translational Studies of Antimalarial Drug Resistance |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Targeting Malaria via Inhibition of Plasmodium Falciparum Enoyl-ACP |
|
Malaria |
|
|
Pharmacovigilance and Antimalarial Treatment in Uganda: A Pilot Survelliance System |
|
Malaria, Epidemiology and Surveillance |
|
|
Falcipain Cysteine Proteases of Malaria Parasites |
Philip J. Rosenthal, MD |
Malaria |
|
|
Utility of Rapid Diagnostic Tests for Malaria |
|
Malaria, Drug and Diagnostics Development, Pediatrics |
|
|
Training In Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building |
|
|
Global Malaria Prevention and Control |
Grant Dorsey, MD |
Malaria |
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health |
|
|
Proteomic Analysis of Antigenic Switching in the Malaria Parasite |
|
Malaria, Residencies, Fellowships, and Postdoctoral Training |
|
|
Interactions Between HIV and Malaria in African Children |
Grant Dorsey, MD |
HIV/AIDS, Malaria |
|
|
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [II] |
Philip J. Rosenthal, MD |
Infectious Disease, Neglected Tropical Diseases (NTDs), Malaria |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Insights into Plasmodium falciparum Interactions with the Human Placenta |
Susan Fisher, PhD |
Malaria, Women's Health, Newborn and Infant Health |
|
|
Development of Anti-Malarial Preclinical Candidates |
Joseph Derisi, PhD |
Malaria |
|
|
Pharmacogenomics of Antimalarial Drugs |
Sunil Parikh, MD, MPH |
Malaria, Genetics, Pharmacology and Drug Treatment |
|
|
The Global Health Group - From Analysis to Action |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Purging the Burden: Expanding Malaria Elimination in Southern Africa |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
A Prospective Cohort Study of the association between HIV and Malaria Incidence and Response to Antimalarial Therapy in African Children |
Philip J. Rosenthal, MD |
HIV/AIDS, Malaria, Pediatrics |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies |
Philip J. Rosenthal, MD |
Malaria |
|
|
Supporting the Implementation of Malaria Prevention and Control Strategies and Relevant Ancillary Activities in the Republic of Uganda |
Grant Dorsey, MD |
Malaria, Implementation and Behavioral Science |
|
|
Translational Studies of Plasmodium Falciparum Infection Dynamics |
Bryan Greenhouse, MD |
Malaria |
|
|
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) |
Diane Havlir, MD |
HIV/AIDS, Malaria |
|
|
Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Comparison of Home-Based Management of Fever/Malaria to Enhanced Health Facility-Based Care in Tororo, Uganda |
Philip J. Rosenthal, MD |
Malaria |
|
|
Chemicals with Potential Activity against Malaria Parasites |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Molecular, Spatial, and Temporal Tracking of Parasites: A Potential Strategy for Malaria Elimination |
Michelle Hsiang, MD |
Malaria |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Evidence for Global Health Advocacy |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness |
|
|
Non- P falciparum and mixed species malarial infection in Zanzibar |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Drug and Diagnostics Development |
|
|
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) |
Diane Havlir, MD |
HIV/AIDS, Malaria |
|
|
PlasmoTrack: Spatiotemporal Tracking of Malaria Parasites |
Bryan Greenhouse, MD |
Malaria |
|
|
The Private Delivery of Malaria Treatment: Generating Information to Rapidly Scale-Up Program |
Dominic Montagu, DrPH |
Malaria |
|
|
Development of Proteome-scale Peptide Bead Suspension Arrays for Immunoprofiling and Vaccine Development by Multi Channel Microfludic Flow Sorting. |
Joseph Derisi, PhD |
Malaria |
|
|
Genome-wide Association Data |
Sunil Parikh, MD, MPH |
Malaria |
|
|
Assessment of Affordable Medicines Facility for Malaria Treatment |
|
Malaria, Health Economics and Effectiveness |
|
|
Training in Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building |
|
|
Immunological Detection and Control of Experimental Uncomplicated Malaria |
|
Malaria |
|
|
Dried Blood Spots on Filter Paper |
Bryan Greenhouse, MD |
Malaria |
|
|
Program for Resistance, Immunology, Surveillance, and Modeling of Malaria in Uganda (PRISM) |
Grant Dorsey, MD |
Malaria, Epidemiology and Surveillance |
|
|
Building a Stronger Evidence Base on Malaria Elimination |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness |
|
|
Swaziland Malaria Indicator Survey 2010 |
Michelle Hsiang, MD |
Malaria, Epidemiology and Surveillance, Health Systems Strengthening |
|
|
Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Women's Health, Pediatrics |
|
|
Accelerating Malaria Elimination in Southern Africa and Beyond: A Country and Global Initiative |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness |
|
|
Innovative Models for Private Malaria Care in Nigeria |
Dominic Montagu, DrPH |
Malaria |
|
|
Chemical Methods for Ferrous Iron Targeted Drug Delivery |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Effector and Regulatory T Cell Responses and Protection from Clinical Malaria |
Margaret Feeney, MD |
Malaria |
|
|
The impact of antimalarials and insecticide resistance on malaria transmission in Uganda |
Melissa Conrad, PhD |
Malaria |
|
|
SmartNet -electronic bednet adherence tool |
Paul Krezanoski, MD |
Malaria |
|
|
International Maternal Pediatrics Adolescent AIDS Clinic (IMPAACT) |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Women's Health, Pediatrics |
|
|
Profiling the Development of Humoral Antimalarial Immunity |
Bryan Greenhouse, MD |
Malaria |
|
|
Impact of Parasitemia on the Development of Cellular Immune Responses to Malaria |
|
Malaria |
|
|
Immunological Detection and Control of Experimental Uncomplicated Malaria |
|
Malaria |
|
|
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI) |
Grant Dorsey, MD |
Malaria |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria |
|
|
Ensuring Proper Malaria Diagnosis and Treatment in Nigeria: Piloting Incentives for Diagnostics in the Private Sector |
Dominic Montagu, DrPH |
Malaria |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria |
|
|
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention |
|
Malaria |
|
|
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland |
Michelle Hsiang, MD |
Malaria |
|
|
Malaria Elimination Surveillance in Swaziland: Investigation of Strategies to Improve Sensitivity and Efficiency for Detection of Secondary Cases |
Michelle Hsiang, MD |
Malaria |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Improving Malaria Treatment Practices in Myanmar's Private Sector: An Evaluation of Incentives for Driving Demand for Diagnostic Tools |
Dominic Montagu, DrPH |
Malaria, Health Economics and Effectiveness, Health Systems Strengthening |
|
|
Using Apicoplast-Deficient Parasites to Identify Anti-Malaria Compounds That Specifically Target This Organelle |
Joseph Derisi, PhD |
Malaria |
|
|
Improving Malaria Diagnosis and Treatment in Nigeria: Taking a Pilot Study to Scale |
Dominic Montagu, DrPH |
Malaria, Health Systems Strengthening |
|
|
A Molecular Strategy to Determine the Origins of Malaria Cases and Map Transmission Potential in Countries Approaching Elimination |
Bryan Greenhouse, MD |
Malaria |
|
|
Swaziland PCR Laboratory Technician Training Contract |
Michelle Hsiang, MD |
Malaria, Training International Scholars and Clinicians |
|
|
Swaziland Serology Technical Assistance |
Michelle Hsiang, MD |
Malaria |
|
|
Preparation of Background Papers to Inform the Gates Foundation Malaria Strategy |
Roland Gosling, PhD, MS, MD |
Malaria |
|
|
Etiology of Non-Malarial Febrile Illnesses in Ugandan Children |
Philip J. Rosenthal, MD |
Malaria, Pediatrics |
|
|
UCSF-GIVI CFAR East Africa Regional Director |
|
HIV/AIDS, Tuberculosis, Malaria, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa |
Diane Havlir, MD |
HIV/AIDS, Malaria, Women's Health, Pediatrics |
|
|
Donation of Primaquine for the UCSF-Sponsored Phase 2A Dose Escalation Study of the Efficacy, Safety and Pharmacokinetics of Low Single-Dose Primaquine for Gametocytocidal Activity against P. Falciparum in Sub-Saharan Africa |
Roland Gosling, PhD, MS, MD |
Malaria, Drug and Diagnostics Development |
|
|
Accelerating progress towards Malaria Eradication: Working across Global, Regional, and National levels, and through Operational Research, to Shrink the Malaria Map |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Systematic Reviews and Guideline Development |
|
|
Berkeley's Minority Health/Global Health Training Program |
Philip J. Rosenthal, MD |
Neglected Tropical Diseases (NTDs), HIV/AIDS, Malaria, Residencies, Fellowships, and Postdoctoral Training |
|
|
Fighting emerging antimalarial drug resistance |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Development of Antimalarial Drug Leads Through Inhibition of Food Vacuole Falcipains |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Eliminating Plasmodium falciparum with artemisinin combination treatments (ACTs) in sub-Saharan Africa |
Roland Gosling, PhD, MS, MD |
Malaria |
|
|
Evaluation of the community impact of START-IPT |
Grant Dorsey, MD |
Malaria |
|
|
Restratification of Epidemiology & Development of Interventions For More Effective Control & Elimination of Malaria in Vietnam |
|
Malaria, Epidemiology and Surveillance, Health Systems Strengthening |
|
|
Plasmodium Falciparum Infection and Interference with Effective B Cell Memory |
Bryan Greenhouse, MD |
Malaria, Immunology, Pediatrics |
|
|
Pharmacokinetic analysis of dihydroartemisinin-piperaquine alongside the START-IPT Study |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Pediatrics |
|
|
Mentoring Translational Researchers for Careers in Pediatric Global Health |
Margaret Feeney, MD |
Malaria, Pediatrics, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training |
|
|
Producing advocacy and summary materials of; malaria control, surveillance strategies, & efficacy of drug based transmission interventions |
Roland Gosling, PhD, MS, MD |
Malaria, Systematic Reviews and Guideline Development |
|
|
Improving the health of children through clinical care and the study of malaria |
Michelle Hsiang, MD |
Malaria |
|
|
Malaria diagnostic strategies and management of febrile patients in malaria-endemic areas |
|
Malaria |
|
|
Impact of Placental Malaria on Neonatal Tolerance and Immunity to Malaria |
Mary Prahl, MD |
Malaria, Newborn and Infant Health |
|
|
Malaria and private sector impacts in health systems |
Arian Hatefi, MD, MS |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Impact analysis of a community-randomized controlled trial in Southern Province, Zambia |
Adam Bennett, PhD, MA |
Malaria, Implementation and Behavioral Science |
|
|
Nursing education in malarial settings |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Drug and Diagnostics Development, Implementation and Behavioral Science, Engagement in Care, Training and Capacity Building, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
Surveillance, monitoring, and evaluation for malaria |
Adam Bennett, PhD, MA |
Malaria, Epidemiology and Surveillance |
|
|
Evaluation of malaria surveillance data processing in Swaziland: Preparation for introducing a cloud-based Disease Surveillance and Risk Mapping (DiSARM) platform |
Felix Holl, MS |
Malaria, Epidemiology and Surveillance |
|
|
Barriers to point-of-care G6PD testing for P.vivax malaria in Malaysia: a qualitative study |
Jessica Jaswal, MS |
Malaria, Drug and Diagnostics Development, Access or Barriers to Care |
|
|
Identifying factors for asymptomatic malaria in the Zambezi region of Namibia: a cross-sectional study |
Patrick McCreesh, MS |
Malaria |
|
|
Care-Seeking Behavior for Fever in Zambezi Region, Namibia: A Cross-Sectional Survey |
Caitlin Moe, MS |
Malaria, Access or Barriers to Care |
|
|
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI) |
Grant Dorsey, MD |
Malaria, Pediatrics |
|
|
Sustaining malaria elimination: the cost of program interventions for malaria elimination and the prevention of reintroduction in the Philippines |
Stephanie Sario, MS |
Malaria |
|
|
Analysis of the rapid policy change toward empirical treatment of fever with artemisinin-based combination therapy in Ebola-burdened areas of Liberia |
Matt Susko, MS |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Policy and Standards of Care |
|
|
Rwanda Malaria Elimination Feasibility Assessment |
Roland Gosling, PhD, MS, MD |
Malaria |
|
|
Preparing Lao PDR for malaria elimination |
Adam Bennett, PhD, MA |
Malaria |
|
|
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland (co-investigator) |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Epidemiology and Surveillance |
|
|
A Novel Myeloid Subset Mediating Tolerance to Malaria |
|
Malaria, Immunology |
|
|
Commission on Investing in Health (CIH) Phase 3: Leveraging Global Health 2035 to Shape the SDGs and the Health Investments of Donor, Low-Income and Middle-Income Countries |
|
Tuberculosis, Malaria, Women's Health, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Preparing Vietnam for Malaria Elimination |
Roland Gosling, PhD, MS, MD |
Malaria, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Therapies |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) |
Michael Harrison, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians |
|
|
High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Pharmacodynamics of Antimalarial Chemoprevention |
Philip J. Rosenthal, MD |
Malaria, Pharmacology and Drug Treatment |
|
|
Interferon-independent mechanisms of malaria restriction by helper T cells |
Mike McCune, MD, PhD |
HIV/AIDS, Malaria, Immunology |
|
|
Hologic - Analytical sensitivity comparison of a new molecular assay for Plasmodium detection with a qualitative nested PCR assay and a quantitative PCR assay 20150330 |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Biomarkers for Malaria Eradication (BIOME) |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Estimating the impact of indoor residual spraying of insecticide using a novel health facility-based malaria surveillance program in Uganda |
Grant Dorsey, MD |
Malaria, Epidemiology and Surveillance |
|
|
Training in Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Clinical care and medical education |
David Sears, MD |
Infectious Disease, HIV/AIDS, Malaria |
|
|
Identifying and targeting populations at risk of malaria |
Hugh Sturrock, PhD |
Malaria, Epidemiology and Surveillance |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
Projecting the Changes in Malaria Distribution in sub-Saharan Africa under Climate Change Scenarios: a Systematic Review |
Knox Kelly, MS |
Malaria |
|
|
Understanding the community acceptability of reactive targeted mass drug administration and indoor residual spraying for malaria elimination: a qualitative study in Zambezi Region, Namibia |
Aly Maglior, MS |
Malaria |
|
|
Applying molecular epidemiology to accelerate to zero |
Bryan Greenhouse, MD |
Malaria, Epidemiology and Surveillance |
|
|
PSI Myanmar-2016 Malaria Writing Workshop |
May Sudhinaraset, PhD |
Malaria, Training International Scholars and Clinicians |
|
|
Results for Malaria Control in Asia and the Pacific (RECAP) |
|
Malaria |
|
|
Novel serologic assays of P. falciparum exposure for improved surveillance in control and elimination |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Investigating the Impact of In Utero HIV or Malaria Exposure on CD4+ T Cell Development |
|
HIV/AIDS, Malaria, Newborn and Infant Health |
|
|
Effector and regulatory T cell responses and protection from clinical malaria |
Margaret Feeney, MD |
Malaria, Drug and Diagnostics Development, Immunology |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Malaria |
|
|
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda |
Grant Dorsey, MD |
Malaria, Epidemiology and Surveillance, Global Strategic Information, Training International Scholars and Clinicians |
|
|
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) |
Diane Havlir, MD |
HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health |
|
|
Mobile Technology for Malaria Elimination: |
Emma Zorensky, MS |
Malaria, Epidemiology and Surveillance |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos Burroughs Wellcome Fund |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Optimizing ACT use for African children in the setting of HIV and malnutrition |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Malnutrition, Micronutrients, Food Insecurity |
|
|
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes |
|
|
Achieving Global Malaria Eradication through Accelerated Regional Elimination |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Systematic Reviews and Guideline Development |
|
|
Development of a transition assessment tool for malaria eliminating countries |
|
Malaria |
|
|
Impact of long-lasting insecticide treated bednets with and without PBO on malaria indicators in Uganda: a cluster randomised trial |
Grant Dorsey, MD |
Malaria |
|
|
The Center for Policy Impact in Global Health & the Capstone Year (phase IV) of the Commission on Investing in Health |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Systematic Reviews and Guideline Development |
|
|
Evidence for Malaria Elimination and Control in Zambia |
Adam Bennett, PhD, MA |
Malaria, Epidemiology and Surveillance |
|
|
Malaria Serology evaluation |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
Global Fund Prospective Country Evaluations |
George Rutherford, MD |
Infectious Disease, Tuberculosis, Malaria, Women's Health, Pediatrics |
|
|
Estimating the Effect of Indoor Residual Spraying on Maternal Morality, Low-Birthweight and Perinatal Mortality Among HIV-Infected Pregnant Women Living in the HAART Era |
Hugh Sturrock, PhD |
HIV/AIDS, Malaria, Women's Health, Newborn and Infant Health |
|
|
Operational Infectious Disease Research - Research Support Across Southeast Asia |
Roland Gosling, PhD, MS, MD |
Malaria, Policy and Standards of Care |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
The Immunologic Impact of In Utero Malaria Exposure and Prenatal Chemoprevention |
Mary Prahl, MD |
Malaria, Newborn and Infant Health |
|
|
Decision Support Platform for Malaria Interventions: Evaluate Productivity Improvements to Indoor Residual Spraying Activity by Spatial Optimizations to Disease Surveillance and Risk Monitoring (DiSARM) Platform |
Vikram Sridharan, MS |
Malaria, Epidemiology and Surveillance |
|
|
Whole Genome Sequence Characterization of Drug Resistant Malarial Strains |
Sumayya Mohammed, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Genetics |
|
|
Factors Associated with G6PD Deficiency Testing Adherence Among P. vivax RDT-positive Individuals Living in Southern Lao PDR |
Resego Bokete, MS |
Malaria, Drug and Diagnostics Development |
|
|
Antimalarial drugs in Ugandan populations |
Melissa Conrad, PhD |
HIV/AIDS, Malaria, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics |
|
|
Malaria Elimination Realised through Community focused Interventions (MERCI) |
Adam Bennett, PhD, MA |
Malaria, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
The impact of antimalarial resistance on malaria transmission in Uganda |
Melissa Conrad, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Innovative intervention for reducing outdoor malaria transmission |
Allison J. Tatarsky, MPH |
Malaria, Epidemiology and Surveillance |
|
|
A Multi-Centric Evaluation of a Device for Automated Malaria Microscopy (EasyScan Go) |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Forest-Goers at Risk: A Case-Control Study of Malaria in Southeast Asia |
Omar Sajjad, MS |
Malaria |
|
|
The impact of vector control interventions on adverse birth outcomes. |
Michelle Roh, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Women's Health, Newborn and Infant Health |
|
|
The impact of antimalarials and insecticide resistance on malaria transmission in Uganda |
Melissa Conrad, PhD |
Malaria |
|
|
DFAT Vector Control Technical Landscape Analysis in the Indo-Pacific |
Allison J. Tatarsky, MPH |
Malaria |
|
|
Time to negativity of Plasmodium falciparum histidine-rich protein 2 rapid diagnostic tests (RDT) in Zambezi region Namibia |
Roland Gosling, PhD, MS, MD |
Malaria, Drug and Diagnostics Development |
|
|
PBO Study: Impact of LLINs with and without PBO in Uganda: a cluster-randomised trial - Innovative Vector Control Consortium (IVCC) |
Grant Dorsey, MD |
Malaria |
|
|
Technical Assistance in Program Management |
Amanda M. Chung, MPH |
Malaria |
|
|
Modeling malaria incidence in Uganda using sentinel site surveillance data |
Bryan Greenhouse, MD |
Malaria, Epidemiology and Surveillance |
|
|
Assessing community-based reactive case detection and treatment of P falciparum and P vivax malaria in high risk populations in Thailand and Laos |
Adam Bennett, PhD, MA |
Malaria |
|
|
Grant to support UCSF Global Health Impact Fund |
Richard Feachem, DSc, PhD |
Malaria |
|
|
UNAM Student Research Projects |
Roland Gosling, PhD, MS, MD |
Malaria, Epidemiology and Surveillance |
|
|
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Malaria |
|
|
Discovery of Novel Antimalarial Leads Targeting Translational Repression in Plasmodium parasites |
Adam Renslo, PhD |
Malaria |
|
|
Planning Grant for a large scale azithromycin trial for prevention of under-5 mortality in Niger |
Thomas Lietman, MD |
Malaria, Eye Disease and Blindness, Pediatrics |
|
|
Building evidence to support safe radical cure for P. vivax in Lao PDR: operational research in collaboration with UCSF |
Adam Bennett, PhD, MA |
Malaria, Pharmacology and Drug Treatment |
|
|
Technical Assistance to develop a malaria specific annex for the Sustainability Transition, and Co-financing Guidance Note through STE-SI |
Sara Fewer |
Malaria, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Malaria prevention during pregnancy and for young children in Uganda |
Erika K. Wallender, MD |
Malaria, Training and Capacity Building, Training International Scholars and Clinicians, Distance learning and mentoring |
|
|
PK/PD modeling to optimize prevention in African children |
Erika K. Wallender, MD |
Malaria, Pharmacology and Drug Treatment |
|
|
P.falciparum infection dynamics and transmission to inform elimination (INDIE) |
Bryan Greenhouse, MD |
Malaria, Pharmacology and Drug Treatment |
|
|
Landscape analysis to generate programmatic and economic evidence to inform the initiative for malaria elimination in Melanesia and Timor-Leste |
Kaitlyn Fox, MBA |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Conducting a transition readiness assessment for malaria (TRA-M), develop a transition plan, and revise the National Malaria Program Strategic Plan |
Sara Fewer |
Malaria, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Regional Investment Case in the Guyana Shield |
Kaitlyn Fox, MBA |
Malaria |
|
|
Global Fund SR2020 |
Starley Shade, PhD, MPH |
Infectious Disease, Tuberculosis, Malaria |
|
|
Enabling Better Planned Transitions of Malaria Programming from Global Fund Financing to Domestic Financing |
Sara Fewer |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Bite Interruption Toward Elimination (BITE) |
Allison J. Tatarsky, MPH |
Malaria, Epidemiology and Surveillance |
|
|
UnMASC: Uganda Malaria Actionable Surveillance in the time of Coronavirus |
Melawit Tekeste, MS |
Malaria, Epidemiology and Surveillance |
|
|